Antimicrobial activity of saturated fatty acids and fatty amines against methicillin-resistant Staphylococcus aureus

Biological and Pharmaceutical Bulletin

Volumn 27, Issue 9, 2004, Pages 1321-1326

  Kitahara, Takashi ^a   Koyama, Nao ^a   Matsuda, Junichi ^a   Aoyama, Yuko ^a   Hirakata, Yoichi ^a   Kamihira, Shimeru ^a   Kohno, Shigeru ^a   Nakashima, Mikiro ^a   Sasaki, Hitoshi ^a  

^a NAGASAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Antimicrobial activity; Fatty acid; Fatty amine; Methicillin resistant staphylococcus aureus (MRSA); Oxygen meter

Indexed keywords

AMINE; AMPICILLIN; ANTIINFECTIVE AGENT; CEFAZOLIN; CEFMETAZOLE; CEFOTIAM; CEFPIROME; DECANOIC ACID; DECYLAMINE; DODECYLAMINE; FLOMOXEF; GENTAMICIN; HABEKACIN; HEXADECYLAMINE; IMIPENEM; LAURIC ACID; MYRISTIC ACID; MYRISTYLAMINE; OCTADECYLAMINE; OCTANOIC ACID; OCTYLAMINE; OXACILLIN; OXYGEN; PALMITIC ACID; SATURATED FATTY ACID; STEARIC ACID; SULTAMICILLIN; TEICOPLANIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VANCOMYCIN; FATTY ACID;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL STRAIN; BACTERICIDAL ACTIVITY; CELL CULTURE; CONTROLLED STUDY; CYTOTOXICITY; DRUG SCREENING; ENDOTHELIUM CELL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PLASMA; CELL LINE; CELL SURVIVAL; COMPARATIVE STUDY; DRUG EFFECT; HUMAN; MICROBIOLOGICAL EXAMINATION; PENICILLIN RESISTANCE; STAPHYLOCOCCUS AUREUS;

AMINES; ANTI-BACTERIAL AGENTS; CELL LINE; CELL SURVIVAL; FATTY ACIDS; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; STAPHYLOCOCCUS AUREUS;

EID: 16644400426     PISSN: 09186158     EISSN: 13475215     Source Type: Journal    
DOI: 10.1248/bpb.27.1321     Document Type: Article

References (36)

1. Centers for Disease Control and Prevention, Morb. Mortal. Wkly. Rep., 46, 813-815 (1997).
2. Centers for Disease Control and Prevention, Morb. Mortal. Wkly. Rep., 42, 597-599 (1993).
3. Centers for Disease Control and Prevention, Am. J. Infect. Control., 24, 380-388 (1996).
4. Richard M. J., Edwards J. R., Culver D. H., Gaynes R. P., Crit. Care Med., 27, 887-892 (1999).
5. Centers for Disease Control and Prevention, Am. J. Infect. Control., 27, 520-532 (1999).
6. Jones R. N., Ballow D. H., Biedenbach D. J., Deinhart J. A., Schentag J., Diagn. Microbiol. Infect. Dis., 31, 437-451 (1998).
7. Centers for Disease Control and Prevention, Morb. Mortal. Wkly. Rep., 51, 565-567 (2002).
8. Centers for Disease Control and Prevention, Morb. Mortal. Wkly. Rep., 51, 902 (2002).
9. Tenover F. C., Weigel L. M., Appelbaum P. C., McDougal L. K., Chaitram J., McAllister S., Clark N., Killgore G., O'Hara C. M., Jevitt L., Patel J. B., Bozdogan B., Antimicrob. Agents Chemother., 48, 275-280 (2004).
10. Alcaraz L. E., Blanco S. E., Puig O. N., Tomas F., Ferretti F. H., J. Theor. Biol., 205, 231-240 (2000).
11. Kubo I, Xiao P., Fujita K., Bioorg. Med. Chem. Lett., 12, 113-116 (2002).
12. Zhao W. H., Hu Z. Q., Okubo S., Hara Y., Shimamura T., Antimicrob. Agents Chemother., 45, 1737-1742 (2001).
13. Zhao W. H., Hu Z. Q., Hara Y., Shimamura T., Antimicrob. Agents Chemother., 46, 2266-2268 (2002).
14. Yamada H., Ohashi K., Atsumi T., Okabe H., Shimizu T., Nishio S., Li X. D., Kosuge K., Watanabe H., Hara Y., J. Hosp. Infect., 53, 229-231 (2003).
15. Kodicek E., Symp. Soc. Exp. Biol., 3, 217-232 (1949).
16. Mcjunkin F. A., Am. Rev. Tuberc., 8, 393-396 (1923).
17. Boissevain C. H., Am. Rev. Tuberc., 13, 84-89 (1926).
18. Platonov G., Am. Rev. Tuberc., 14, 549-555 (1926).
19. Pollock M. R., Symp. Soc. Exp. Biol., 3, 193-216 (1949).
20. Kitahara T., Koyama N., Matsuda J., Hirakata Y., Kamihira S., Kohno S., Nakashima M., Sasaki H., Biol. Pharm. Bull., 26, 1229-1234 (2003).
21. Amano Y., Okumura C., Yoshida M., Katayama H., Unten S., Arai J., Tagawa T., Hoshina S., Hashimoto H., Ishikawa H., Human Cell., 12, 3-10 (1999).
22. National Committee for Clinical Laboratory Standards. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 5th ed. Approved standard. NCCLS document M7-A5, 2001.
23. Lorian V., "Antibiotics in Laboratory Medicine," 3rd ed., Williams & Wilkins, Baltimore, 1991, pp. 434-444.
24. Burgalassi S., Chetoni P., Monti D., Saettone M. F., Toxicol. Lett., 122, 1-8 (2001).
25. Witte W., J. Antimicrob. Chemother., 44 (Suppl. A), 1-9 (1999).
26. Spencer R. C., Eur. J. Clin. Microbiol. Infect. Dis., 15, 281-285 (1996).
27. Reynolds P. E., Brown D. F. J., FEBS, 192, 28-32 (1985).
28. Utsui Y., Yokota T., Antimicrob. Agents Chemother., 28, 397-403 (1985).
29. Nieman C., Bacteriol Reviews., 18, 147-163 (1954).
30. Foster J. W., Wynne E. S., J. Bacteriol., 55, 623-625 (1948).
31. Sheu C. W., Freese E., J. Bacteriol., 115, 869-875 (1973).
32. Galbraith H., Miller T. B., J. Appl. Bact., 36, 647-658 (1973).
33. Jono K., Uemura T., Kuno M., Higashide E., Yakugaku Zasshi., 105, 751-759 (1985).
34. Widmer A. F., Frei R., "Manual of Clinical Microbiology," 8th ed., American Society for Microbiology, Washington, D.C., 2003, pp. 81-96.
35. Jono K., Takayama T., Kuno M., Higashide E., Chem. Pharm. Bull., 34, 4215-4224 (1986).
36. Sakai N., Kobayashi S., Aso S., Omikawa H., Nakada K., Iizuka S., J. Antibact. Antifung. Agents, 17, 377-380 (1989).